Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Savary

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemistry|January 19, 1982
Biochemical characterization of the sixth component (C6) of human complementW P Kolb, L M Kolb, J R Savary
Environmental Health Perspectives|June 1, 1987
Biological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studiesW P Kolb, J R Savary, C M Troup, et al.
AIDS (London, England)|January 11, 2000
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvantR B Moss, E Webb, W K Giermakowska, et al.
AIDS Research and Human Retroviruses|July 22, 1998
A primer on HIV type 1-specific immune function and REMUNER B Moss, W K Giermakowska, J R Savary, et al.
Journal of Human Virology|April 25, 2000
CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE)R B Moss, W K Giermakowska, J P Diveley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemistry|January 19, 1982
Biochemical characterization of the sixth component (C6) of human complementW P Kolb, L M Kolb, J R Savary
Environmental Health Perspectives|June 1, 1987
Biological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studiesW P Kolb, J R Savary, C M Troup, et al.
AIDS (London, England)|January 11, 2000
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvantR B Moss, E Webb, W K Giermakowska, et al.
AIDS Research and Human Retroviruses|July 22, 1998
A primer on HIV type 1-specific immune function and REMUNER B Moss, W K Giermakowska, J R Savary, et al.
Journal of Human Virology|April 25, 2000
CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE)R B Moss, W K Giermakowska, J P Diveley, et al.
Pageof 1